Wolff Stefani 4
4 · Nurix Therapeutics, Inc. · Filed Aug 10, 2022
Insider Transaction Report
Form 4
Wolff Stefani
EVP and COO
Transactions
- Award
Employee Stock Option (right to buy)
2022-08-09+110,375→ 110,375 totalExercise: $18.50Exp: 2032-08-08→ Common Stock (110,375 underlying)
Footnotes (1)
- [F1]The stock option vests as to 1/48 of the total shares monthly beginning September 9, 2022 until the option is fully vested on August 9, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date.